Special Correspondent MUMBAI – The Hindu

[ad_1]

Wellthy Therapeutics, a digital therapeutics (DTx) companies, has raised $4 million (₹30 crore) from Saama Capital, as part of its Pre Series A round for a 16% stake in the company.

The company works with leading insurance, pharmaceutical, medical device companies and large hospitals to deliver clinically-validated digital therapies that improve the health outcomes and quality of life of patients with a chronic condition.

“The funding will allow us to invest further into improving patient outcomes and generate further real world evidence, while expanding our therapeutic portfolio, geographic and stakeholder reach,” says Abhishek Shah, CEO and co-founder, Wellthy Therapeutics.

You have reached your limit for free articles this month.

Register to The Hindu for free and get unlimited access for 30 days.

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.

Personalised recommendations

A select list of articles that match your interests and tastes.

Faster pages

Move smoothly between articles as our pages load instantly.

Dashboard

A one-stop-shop for seeing the latest updates, and managing your preferences.

Briefing

We brief you on the latest and most important developments, three times a day.

Not convinced? Know why you should pay for news.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

[ad_2]

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *